Which has the lower trailing P/E, DXCM or RMD?

RMD has the lower trailing P/E: DXCM trades at 34.57 and RMD at 21.34. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DXCM or RMD?

Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus RMD at 12.08%.

Does DXCM or RMD pay a bigger dividend?

RMD pays a dividend (1.10% yield), while DXCM has no payments in the available dividend history.

Is DXCM or RMD more profitable?

RMD runs the higher net margin — DXCM at 20.12% versus RMD at 26.94%.

How have DXCM and RMD total returns compared?

Over the past 10 years, DXCM delivered 13.57% and RMD delivered 14.06% annualized total return. Past performance doesn't predict future results.

DexCom, Inc. (DXCM) vs ResMed Inc. (RMD)

A side-by-side comparison of DexCom, Inc. and ResMed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

DXCM

DexCom, Inc.

$33.01B

$87.47HealthcareDelayed quote: Sep 24, 2026, 4:00 PM EDT

RMD

ResMed Inc.

$32.19B

$221.89HealthcareDelayed quote: Sep 24, 2026, 4:00 PM EDT

Total return — DXCM vs RMD

growth of $100 · dividends reinvested · last 10y

DXCM +260.7% (+13.7%/yr)RMD +271.7% (+14.0%/yr)RMD compounded faster over this window

DXCM RMD

DXCM vs RMD: by the numbers

•DXCM is the larger company ($33.01B vs $32.19B market cap).
•RMD trades at the lower trailing earnings multiple (21.34 vs 34.57 P/E), one valuation lens rather than an overall verdict.
•RMD converts more revenue to profit (26.94% vs 20.12% net margin).
•DXCM grew revenue faster over the past five years (18.03% vs 12.08% CAGR).
•RMD pays a dividend (1.10% yield), while DXCM has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	DXCM	RMD
P/E ratio	34.57	21.34
Forward P/E	32.79	18.35
P/S ratio	6.64	5.69
P/B ratio	12.59	4.89
EV / EBITDA	23.73	15.09
FCF yield	4.26%	N/A

Profitability

Metric	DXCM	RMD
Gross margin	62.47%	61.16%
Operating margin	22.92%	33.48%
Net margin	20.12%	26.94%
ROE	38.14%	23.13%
ROIC	21.71%	19.18%

Dividends

Metric	DXCM	RMD
Dividend yield	N/A	1.10%
Payout ratio	N/A	23.08%

Growth (annualized)

Metric	DXCM	RMD
Revenue CAGR (5Y)	18.03%	12.08%
EPS CAGR (5Y)	10.31%	26.14%
FCF CAGR (5Y)	69.49%	21.62%
Total return CAGR (5Y)	-9.57%	-5.02%

Frequently asked

Which has the lower trailing P/E, DXCM or RMD?: RMD has the lower trailing P/E: DXCM trades at 34.57 and RMD at 21.34. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DXCM or RMD?: Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus RMD at 12.08%.
Does DXCM or RMD pay a bigger dividend?: RMD pays a dividend (1.10% yield), while DXCM has no payments in the available dividend history.
Is DXCM or RMD more profitable?: RMD runs the higher net margin — DXCM at 20.12% versus RMD at 26.94%.
How have DXCM and RMD total returns compared?: Over the past 10 years, DXCM delivered 13.57% and RMD delivered 14.06% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DXCM analysis Full RMD analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio ResMed P/E ratio ResMed dividend yield DexCom ROE ResMed ROE DexCom operating margin ResMed operating margin DexCom revenue growth ResMed revenue growth DexCom free cash flow ResMed free cash flow

DexCom & ResMed appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.